Table 1. Clinical characteristics between PDR group and control group.
| Clinical characteristics | PDR | Control | t | P |
| Age, yr (mean±SD range) | 55.80±8.00 | 54.90±10.40 | 0.73 | 0.46 |
| FBG, mmol/L (mean±SD range) | 6.97±2.06 | 5.29±0.35 | 8.04 | 0.00 |
| TG, mmol/L (mean±SD range) | 2.03±1.64 | 1.17±0.53 | 4.99 | 0.00 |
| TC, mmol/L (mean±SD range) | 5.22±0.99 | 4.25±0.80 | 7.58 | 0.00 |
| CREA, umol/L(mean±SD range) | 78.30±46.30 | 83.00±17.10 | -0.95 | 0.34 |
| BUN,mmol/L (mean±SD range) | 6.67±2.43 | 4.47±1.14 | 8.19 | 0.00 |
| UA,umol/L(mean±SD range) | 318.00±76.00 | 268±823 | 4.46 | 0.00 |
| WBC,109/L(mean±SD range) | 6.60±1.80 | 5.80±1.30 | 3.68 | 0.00 |
| RBC,1012/L(mean±SD range) | 4.37±0.51 | 4.29±0.31 | 1.39 | 0.16 |
| Hb,g/l (mean±SD range) | 132.00±17.00 | 133.00±12.00 | -0.77 | 0.44 |
| Blood platelet,109/L (mean±SD range) | 223.00±97.00 | 203.00±55.00 | 1.72 | 0.09 |
| Neutrophil count,109/L(mean±SD range) | 4.20±1.60 | 3.40±1.00 | 4.01 | 0.00 |
| Intermediate cell count,109/L(mean±SD range) | 0.53±0.22 | 0.48±0.17 | 1.79 | 0.08 |
| Lymphocyte count,109/L (mean±SD range) | 1.88±0.52 | 1.91±0.51 | -0.41 | 0.69 |
| HCT(mean±SD range) | 0.38±0.05 | 0.14±0.03 | 6.07 | 0.00 |
| MPV,fL(mean±SD range) | 10.09±0.92 | 9.46±0.93 | 4.87 | 0.00 |
SD, standard deviation